이식형 심장 모니터 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Implantable Cardiac Monitor Market size is expected to reach USD 2.14 Billion in 2034 from USD 1.15 Billion (2025) growing at a CAGR of 7.18% during 2026-2034.

The global implantable cardiac monitor market has shown strong growth due to increasing heart disease cases. These devices help monitor heart rhythms over a long period. Rising awareness about early diagnosis and preventive care has boosted demand. Aging populations and lifestyle-related health issues have also contributed to market expansion.

Key drivers include technological advancements and miniaturization of devices. Modern monitors are smaller, more accurate, and capable of wireless data transmission. Growing healthcare spending and improved access to cardiac care support adoption. Hospitals and cardiology centers are increasingly recommending long-term monitoring for high-risk patients.

In the future, the market is expected to grow as remote patient monitoring becomes more common. Integration with digital health platforms will create new opportunities. However, high device costs and regulatory requirements may limit adoption in some regions. Despite this, increasing focus on heart health will sustain demand.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Arrhythmia

• Atrial Fibrillation
• Bradycardia
• Others

By End-User

• Hospitals
• Specialized Cardiac Centers
• Ambulatory Surgical Centers

COMPANIES PROFILED

• Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE Co KG, MicroPort Scientific Corporation, LivaNova PLC, Angel Medical Systems, Inc, Medico SpA, InfoBionic, BioTelemetry, Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET: BY ARRHYTHMIA 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Arrhythmia
• 4.2. Atrial Fibrillation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Bradycardia Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET: BY END-USER 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End-user
• 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Specialized Cardiac Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Arrhythmia
  • 6.2.2 By End-user
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Arrhythmia
  • 6.3.2 By End-user
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Arrhythmia
  • 6.4.2 By End-user
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Arrhythmia
  • 6.5.2 By End-user
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Arrhythmia
  • 6.6.2 By End-user
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL IMPLANTABLE CARDIAC MONITOR INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Medtronic Plc
  • 8.2.2 Abbott Laboratories
  • 8.2.3 Boston Scientific Corporation
  • 8.2.4 Biotronik SE & Co. KG
  • 8.2.5 MicroPort Scientific Corporation
  • 8.2.6 LivaNova PLC
  • 8.2.7 Angel Medical SystemsInc
  • 8.2.8 Medico S.P.A
  • 8.2.9 InfoBionic
  • 8.2.10 BioTelemetryInc